This idea is strengthened by the Yu et al. study that shows ‘miR-155’ (that we know to be involved in GD) is a direct target of the ‘MEG3’ which acts by sponging ‘miR-155’ in acute myeloid leukemia (AML) cells112. Here, MEG3 is linked to acute myeloid leukemia.